Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine
about
Towards medication-enhancement of cognitive interventions in schizophreniaMeta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophreniaEffects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategyMemantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.Are we studying and treating schizophrenia correctly?Potential role of the combination of galantamine and memantine to improve cognition in schizophreniaMemantine: a review of possible uses in child and adolescent psychiatryWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Pharmacotherapy for treatment-resistant schizophrenia.Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic.Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial.Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover studyPharmacotherapy for treatment-refractory schizophrenia.Emerging drugs for schizophrenia.Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.Newer antipsychotics and upcoming molecules for schizophrenia.Glutamate receptor abnormalities in schizophrenia: implications for innovative treatments.Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.Tackling negative symptoms of schizophrenia with memantineMemantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.Critics on "adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study"Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study.Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer's Disease, and Parkinson's Disease.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
P2860
Q26860777-E6A6BB9C-F5C2-4052-85EC-85088BB6D4B4Q28248687-A3176648-5453-4364-BDCE-EB1D86474A14Q30355399-700DBA48-0496-4660-B349-961777E760B1Q30366961-2C29D11E-5FFC-49DD-9CC4-BCADC23C7640Q30465313-A89DC6D2-A24E-42B4-B17D-6EE07799484CQ33905343-9683F561-483C-453D-BA11-0C8AD6059DBCQ34344303-B0D8A2C6-D893-4878-9C6F-1E3CF03467D2Q34640811-AD78F775-2DAA-426C-BCCB-A48160C84F67Q34879109-A7834602-AD84-485E-8FCF-BAE6C1C31AF3Q35738997-B8A1C82E-9926-4758-95A6-6E9819CD3902Q35802177-8A6FC128-21A6-4877-8233-54E8889913A4Q36279413-359F58A1-F6DB-480E-9CBB-3BE978835F87Q37111872-147FD706-80FF-4FE7-9E51-1F5B18700525Q37831352-AA1E7F50-00FB-4243-ABCD-A10AC981667EQ37874626-FFADF633-9202-4BCA-9AC0-6A220146DF40Q37979291-4A94EA14-FD45-4C05-B52E-211771515E8AQ38094930-318298D8-C0CF-45D2-B4E5-14EDD209428CQ38151703-115C9493-BCFE-4A3B-9E62-11CF7BCF35E5Q38256894-0B7ACF52-0094-401C-9EAD-8319C7E0DA72Q38647035-13FD3A49-90EA-4163-AD28-882A4E76EAE2Q38718345-4BEA0143-FBF4-4F71-92E9-B6F0A5BD8AADQ38829187-3DDDC3E2-8CBF-4FA9-8DC7-78E24097A947Q39035895-41590603-B8C8-4A89-9BDB-E7C5A39C64EAQ39308929-37EE3A09-CF8C-4F30-ADF3-D2EFBD3403FFQ41513149-7889C098-5025-41EC-BD00-C8E468429905Q42137909-C7B8458D-C65D-4E46-A041-06FD9F7E77CEQ47717590-5A1EA1E0-E3A6-446F-B52A-B623A8F74B0BQ47902795-6799CEC8-B857-42B2-9A29-737AB8D3CEA2Q54975082-A5A0423A-638C-45F9-907E-C1D227E218FCQ58561523-DA574D95-B107-43ED-98B8-37EBC63BF4A5
P2860
Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Improvement of negative and po ...... as add-on therapy to clozapine
@ast
Improvement of negative and po ...... as add-on therapy to clozapine
@en
Improvement of negative and po ...... as add-on therapy to clozapine
@nl
type
label
Improvement of negative and po ...... as add-on therapy to clozapine
@ast
Improvement of negative and po ...... as add-on therapy to clozapine
@en
Improvement of negative and po ...... as add-on therapy to clozapine
@nl
prefLabel
Improvement of negative and po ...... as add-on therapy to clozapine
@ast
Improvement of negative and po ...... as add-on therapy to clozapine
@en
Improvement of negative and po ...... as add-on therapy to clozapine
@nl
P2093
P50
P3181
P356
P1476
Improvement of negative and po ...... as add-on therapy to clozapine
@en
P2093
Dalton W Medeiros
David de Lucena
Fabiano Alves Gomes
Larriany F Giglio
Mariana Pedrini
Seetal Dodd
P304
P3181
P356
10.4088/JCP.08M04935GRY
P407
P50
P577
2009-10-01T00:00:00Z